P929: IXAZOMIB AND DARATUMUMAB WITHOUT DEXAMETHASONE (I-DARA) IN ELDERLY FRAIL RELAPSING MYELOMA (RRMM) PATIENTS: RESULTS OF THE PHASE 2 STUDY IFM 2018-02 OF THE INTERGROUPE FRANCOPHONE DU MYELOME (IFM). (23rd June 2022) - Macro, M.; Touzeau, C.; Mariette, C.; Manier, S.; Brechignac, S.; Vincent, L.; Hebraud, B.; Decaux, O.; Schulmann, S.; Lenoir, C.; Godmer, P.; Farge, A.; et al.